One Year After Adderall Shortage First Declared, Rep. Spanberger Seeks Answers From DEA, FDA on Efforts to Stop Ongoing Shortages
October 13, 2023
October 13, 2023
WASHINGTON, Oct. 13 -- Rep. Abigail Spanberger, D-Virginia, issued the following news release:
U.S. Representative Abigail Spanberger today is leading an effort urging the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to provide more answers on their work to end shortages of Attention Deficit Hyperactivity Disorder (ADHD) medications -- including Adderall.
On October 12, 2022, the FDA declared a shortage of ingredients used to manufacture . . .
U.S. Representative Abigail Spanberger today is leading an effort urging the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to provide more answers on their work to end shortages of Attention Deficit Hyperactivity Disorder (ADHD) medications -- including Adderall.
On October 12, 2022, the FDA declared a shortage of ingredients used to manufacture . . .